US Bancorp’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.38M | Sell |
118,415
-15,636
| -12% | -$182K | ﹤0.01% | 1002 |
|
|
2025
Q1 | $996K | Buy |
134,051
+14,764
| +12% | +$110K | ﹤0.01% | 1102 |
|
|
2024
Q4 | $715K | Sell |
119,287
-43,819
| -27% | -$263K | ﹤0.01% | 1279 |
|
|
2024
Q3 | $835K | Buy |
163,106
+71,065
| +77% | +$364K | ﹤0.01% | 1218 |
|
|
2024
Q2 | $333K | Sell |
92,041
-9,063
| -9% | -$32.8K | ﹤0.01% | 1733 |
|
|
2024
Q1 | $325K | Sell |
101,104
-9,873
| -9% | -$31.7K | ﹤0.01% | 1761 |
|
|
2023
Q4 | $544K | Buy |
110,977
+105,077
| +1,781% | +$515K | ﹤0.01% | 1438 |
|
|
2023
Q3 | $32.2K | Sell |
5,900
-1,042
| -15% | -$5.68K | ﹤0.01% | 2648 |
|
|
2023
Q2 | $46.6K | Sell |
6,942
-48
| -0.7% | -$322 | ﹤0.01% | 2512 |
|
|
2023
Q1 | $61.7K | Buy |
6,990
+362
| +5% | +$3.2K | ﹤0.01% | 2406 |
|
|
2022
Q4 | $50.6K | Sell |
6,628
-3,938
| -37% | -$30.1K | ﹤0.01% | 2513 |
|
|
2022
Q3 | $75K | Sell |
10,566
-24,744
| -70% | -$176K | ﹤0.01% | 2312 |
|
|
2022
Q2 | $286K | Sell |
35,310
-13,282
| -27% | -$108K | ﹤0.01% | 1715 |
|
|
2022
Q1 | $674K | Buy |
48,592
+157
| +0.3% | +$2.18K | ﹤0.01% | 1383 |
|
|
2021
Q4 | $1.36M | Buy |
48,435
+9,233
| +24% | +$259K | ﹤0.01% | 1076 |
|
|
2021
Q3 | $1.33M | Buy |
39,202
+1,679
| +4% | +$57K | ﹤0.01% | 1048 |
|
|
2021
Q2 | $1.53M | Buy |
37,523
+9,906
| +36% | +$405K | ﹤0.01% | 995 |
|
|
2021
Q1 | $1.11M | Buy |
27,617
+3,009
| +12% | +$121K | ﹤0.01% | 1079 |
|
|
2020
Q4 | $1.46M | Sell |
24,608
-264
| -1% | -$15.6K | ﹤0.01% | 940 |
|
|
2020
Q3 | $1.21M | Buy |
24,872
+1,992
| +9% | +$96.9K | ﹤0.01% | 913 |
|
|
2020
Q2 | $1.11M | Buy |
22,880
+14,412
| +170% | +$697K | ﹤0.01% | 918 |
|
|
2020
Q1 | $235K | Buy |
8,468
+8,467
| +846,700% | +$235K | ﹤0.01% | 1559 |
|
|
2019
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 3577 |
|